INCLINE VILLAGE, Nev.,
April 16, 2018 /PRNewswire/ -- PDL
BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) today announced
that the Company will hold its annual meeting of stockholders on
Friday, June 8, 2018, at 10:00 a.m. Pacific Time for all stockholders of
record on May 4, 2018. The meeting
will take place at the Hyatt Regency Hotel in Incline Village, Nevada.
About PDL BioPharma
PDL seeks to provide a
significant return for its shareholders by acquiring and managing a
portfolio of companies, products, royalty agreements and debt
facilities in the biotech, pharmaceutical and medical device
industries. In 2012, PDL began providing alternative sources of
capital through royalty monetizations and debt facilities, and in
2016, the Company began acquiring commercial-stage products and
launching specialized companies dedicated to the commercialization
of these products. To date, PDL has consummated 17 of such
transactions, of which nine are active and outstanding. The Company
has one debt transaction outstanding, representing deployed and
committed capital of $20.0 million:
CareView Communications, Inc.; PDL has one hybrid royalty/debt
transaction outstanding, representing deployed and committed
capital of $44.0 million: Wellstat
Diagnostics, LLC; and PDL has five royalty transactions
outstanding, representing deployed and committed capital of
$396.1 million and $397.1 million, respectively: KYBELLA®, AcelRx
Pharmaceuticals, Inc. The Regents of the University of Michigan, Viscogliosi Brothers, LLC
and Depomed, Inc. PDL's equity and loan investments in Noden Pharma
DAC, Inc. and Noden Pharma USA,
Inc. (together with their subsidiaries, "Noden") represent deployed
and committed capital of $179.0
million and $202.0 million,
respectively, and PDL's converted equity and loan investment in
LENSAR, Inc. represents deployed capital of $40.0 million.
The Company operates in three segments designated as Income
Generating Assets, Pharmaceutical and Medical Devices.
NOTE: PDL, PDL BioPharma, the PDL logo and the PDL
BioPharma logo are trademarks or registered trademarks of, and are
proprietary, to PDL BioPharma, Inc. which reserves all rights
therein.
View original content with
multimedia:http://www.prnewswire.com/news-releases/pdl-biopharma-to-hold-annual-meeting-of-stockholders-on-june-8-2018-300630005.html
SOURCE PDL BioPharma, Inc.